Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H28FN3O6S |
Molecular Weight | 481.538 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
InChI
InChIKey=BPRHUIZQVSMCRT-VEUZHWNKSA-N
InChI=1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1
Molecular Formula | C22H28FN3O6S |
Molecular Weight | 481.538 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:44:27 UTC 2023
by
admin
on
Fri Dec 15 15:44:27 UTC 2023
|
Record UNII |
413KH5ZJ73
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C10BX09
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
WHO-ATC |
C10BX14
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
WHO-VATC |
QC10BX05
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
WHO-ATC |
C10BX07
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
WHO-ATC |
C10AA07
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
NDF-RT |
N0000000121
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
420513
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
WHO-ATC |
A10BH52
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
WHO-ATC |
C10BA06
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
WHO-VATC |
QC10AA07
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
WHO-ATC |
C10BX10
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
NCI_THESAURUS |
C1655
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
WHO-ATC |
C10BX13
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
LIVERTOX |
NBK548620
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
WHO-ATC |
C10BX05
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
NDF-RT |
N0000175589
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
||
|
WHO-VATC |
QC10BA06
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
38545
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
C66523
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
100000088232
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
DTXSID8048492
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
ROSUVASTATIN
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
446157
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
C422923
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
2406
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
Rosuvastatin
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
413KH5ZJ73
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
413KH5ZJ73
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
301542
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | RxNorm | ||
|
287714-41-4
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
CHEMBL1496
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
SUB20634
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
DB01098
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
m9672
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | Merck Index | ||
|
2954
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
8021
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY | |||
|
7317
Created by
admin on Fri Dec 15 15:44:27 UTC 2023 , Edited by admin on Fri Dec 15 15:44:27 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
EXCRETED UNCHANGED |
FECAL
|
||
|
TARGET -> INHIBITOR |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TRANSPORTER -> SUBSTRATE |
Km
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
BINDER->LIGAND |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE LESS ACTIVE -> PARENT |
N-desmethyl rosuvastatin has approximately one-sixth to one-half the HMG-CoA reductase inhibitory activity of the parent compound.
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||